Search

everythinglearnresearchcommunity

for

Search:↓

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Cyproterone acetate is used for topical treatment of diseases dependent on male hormones.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

Cyproterone acetate reduces hair growth and oil production.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

The eucalyptus oil system improved skin delivery of hormones, but safety concerns remain.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Cyproterone acetate temporarily reduces hair growth in women with idiopathic hirsutism but doesn't change hormone levels.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Both cyproterone acetate and spironolactone effectively reduce hair growth in women with hirsutism.

Both finasteride and drospirenone treatments improved symptoms and increased pregnancy rates in women with polycystic ovary syndrome.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Leuprolide plus estrogen is more effective than oral contraceptives for reducing hirsutism.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.